Company intelligence / Profile preview

DRL US

Agoura Hills, California, USAdrlgroup.net ↗

Ownership: Private
Development stage: Other

Overview

DRL US provides human biosamples (FFPE/fresh/frozen tissue), primary cell lines, 3D tumor models/organoids, and custom assay/model development services to pharma and diagnostics companies. They offer consulting on project design and legal/ethical compliance. Their network spans North America, Europe, Asia, and Africa with labs in America and Europe ensuring quality control. They do not develop their own drugs but enable clients' discovery/preclinical programs.

Modalities: Cell therapy (primary cell lines, organoids)3D tumor models/organoidsAssays for drug development
Industry: Contract Research Organization

Beyond the preview

Go deeper on DRL US.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DRL US.

Explore the full profile